Skip to main content
Have a personal or library account? Click to login
Targeting the PD-1/PD-L1 axis in the treatment of lung cancer Cover

Targeting the PD-1/PD-L1 axis in the treatment of lung cancer

Forum of Clinical Oncology
Volume 7 (2016): Issue 1 (March 2016)
By: Alexios Matikas and  Sofia Aggelaki  
Open Access
|Sep 2016
Authors

Authors

Alexios Matikas

almatikas@gmail.com

Sofia Aggelaki

DOI: https://doi.org/10.1515/fco-2015-0021 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 17 - 27
Submitted on: Feb 16, 2016
Accepted on: Feb 16, 2016
Published on: Sep 17, 2016
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
NSCLC,
PD-1,
PD-L1,
Nivolumab,
Pembrolizumab
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2016 Alexios Matikas, Sofia Aggelaki, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 7 (2016): Issue 1 (March 2016)
Previous article
Next article